Cardiovascular risk models

doi:10.1136/bmj.39262.643090.47

Editorial

. 2007 Jul 21;335(7611):107-8.

doi: 10.1136/bmj.39262.643090.47. Epub 2007 Jul 6.

Cardiovascular risk models

Luc Bonneux

PMID: 17616541
PMCID: PMC1925216
DOI: 10.1136/bmj.39262.643090.47

Editorial

Cardiovascular risk models

Luc Bonneux. BMJ. 2007.

. 2007 Jul 21;335(7611):107-8.

doi: 10.1136/bmj.39262.643090.47. Epub 2007 Jul 6.

Author

Luc Bonneux

PMID: 17616541
PMCID: PMC1925216
DOI: 10.1136/bmj.39262.643090.47

Abstract

The moral implications of models based on absolute risk need to be better understood

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Hippisley-Cox J, et al. BMJ. 2007 Jul 21;335(7611):136. doi: 10.1136/bmj.39261.471806.55. Epub 2007 Jul 5. BMJ. 2007. PMID: 17615182 Free PMC article.

Cited by

Identifying individuals for primary cardiovascular disease prevention in UK general practice: priorities and resource implications.
Holt TA, Thorogood M, Griffiths F, Munday S, Stables D. Holt TA, et al. Br J Gen Pract. 2008 Jul;58(552):495-8. doi: 10.3399/bjgp08X319468. Br J Gen Pract. 2008. PMID: 18611316 Free PMC article.
Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study.
Hill S, Spink J, Cadilhac D, Edwards A, Kaufman C, Rogers S, Ryan R, Tonkin A. Hill S, et al. BMC Public Health. 2010 Mar 4;10:108. doi: 10.1186/1471-2458-10-108. BMC Public Health. 2010. PMID: 20199692 Free PMC article.

References

1. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK. A new cardiovascular disease risk score for the UK. BMJ 2007. doi: 10.1136/bmj.39261.471806.55 - DOI - PMC - PubMed
1. Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995;346:1467-71. - PubMed
1. Essink-Bot ML, Kruijshaar ME, Barendregt JJ, Bonneux LG. Evidence-based guidelines, time-based health outcomes, and the Matthew effect. Eur J Public Health 2007;17:314-7. - PubMed
1. Flesch M, Rosenkranz S, Erdmann E, Bohm M. Alcohol and the risk of myocardial infarction. Basic Res Cardiol 2001;96:128-35. - PubMed
1. Franco OH, Bonneux L, de Laet C, Peeters A, Steyerberg EW, Mackenbach JP. The polymeal: a more natural, safer, and probably tastier (than the polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 2004;329:1447-50. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

[1] Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK. A new cardiovascular disease risk score for the UK. BMJ 2007. doi: 10.1136/bmj.39261.471806.55 - DOI - PMC - PubMed

[2] Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK. A new cardiovascular disease risk score for the UK. BMJ 2007. doi: 10.1136/bmj.39261.471806.55 - DOI - PMC - PubMed

[3] Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995;346:1467-71. - PubMed

[4] Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995;346:1467-71. - PubMed

[5] Essink-Bot ML, Kruijshaar ME, Barendregt JJ, Bonneux LG. Evidence-based guidelines, time-based health outcomes, and the Matthew effect. Eur J Public Health 2007;17:314-7. - PubMed

[6] Essink-Bot ML, Kruijshaar ME, Barendregt JJ, Bonneux LG. Evidence-based guidelines, time-based health outcomes, and the Matthew effect. Eur J Public Health 2007;17:314-7. - PubMed

[7] Flesch M, Rosenkranz S, Erdmann E, Bohm M. Alcohol and the risk of myocardial infarction. Basic Res Cardiol 2001;96:128-35. - PubMed

[8] Flesch M, Rosenkranz S, Erdmann E, Bohm M. Alcohol and the risk of myocardial infarction. Basic Res Cardiol 2001;96:128-35. - PubMed

[9] Franco OH, Bonneux L, de Laet C, Peeters A, Steyerberg EW, Mackenbach JP. The polymeal: a more natural, safer, and probably tastier (than the polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 2004;329:1447-50. - PMC - PubMed

[10] Franco OH, Bonneux L, de Laet C, Peeters A, Steyerberg EW, Mackenbach JP. The polymeal: a more natural, safer, and probably tastier (than the polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 2004;329:1447-50. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cardiovascular risk models

Cardiovascular risk models

Author

Abstract

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources